Eight weeks of Paritaprevir/r/Ombitasvir + Dasabuvir in HCV genotype 1b with mild-moderate fibrosis: Results from a real-world cohort.
Liver Int
; 39(1): 90-97, 2019 01.
Article
in En
| MEDLINE
| ID: mdl-30160363
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antiviral Agents
/
Sulfonamides
/
Uracil
/
Carbamates
/
Hepatitis C, Chronic
/
Macrocyclic Compounds
/
Liver Cirrhosis
/
Anilides
Type of study:
Clinical_trials
/
Observational_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Europa
Language:
En
Journal:
Liver Int
Journal subject:
GASTROENTEROLOGIA
Year:
2019
Type:
Article
Affiliation country:
Spain